255
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Doxorubicin hydrochloride loaded nanotextured films as a novel drug delivery platform for ovarian cancer treatment

ORCID Icon, , &
Pages 1289-1301 | Received 17 Mar 2020, Accepted 11 Sep 2020, Published online: 23 Sep 2020

References

  • Abedalwafa M, Wang FJ, Wang L, Li CJ. 2013. Biodegradable poly-epsilon-caprolactone (PCL) for tissue engineering applications: a review. Rev Adv Mater Sci. 34(2):123–140.
  • Adjei IM, Blanka S. 2015. Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach. J Funct Biomater. 6(1):81–103.
  • Allan C, Ker A, Smith CA, Tsimbouri PM, Borsoi J, O’Neill S, Gadegaard N, Dalby MJ, Meek RMD. 2018. Osteoblast response to disordered nanotopography. J Tissue Eng. 9:2041731418784098.
  • Alves NM, Pashkuleva I, Reis RL, Mano JF. 2010. Controlling cell behavior through the design of polymer surfaces. Small. 6(20):2208–2220.
  • Aminuddin NI, Ahmad R, Akbar SA, Pingguan-Murphy B. 2016. Osteoblast and stem cell response to nanoscale topographies: a review. Sci Technol Adv Mater. 17(1):698–714.
  • Berzat A, Hall A. 2010. Cellular responses to extracellular guidance cues. Embo J. 29(16):2734–2745. eng.
  • Biggs MJP, Richards RG, Dalby MJ. 2010. Nanotopographical modification: a regulator of cellular function through focal adhesions. Nanomedicine. 6(5):619–633. English.
  • Dalby MJ, Gadegaard N, Oreffo ROC. 2014. Harnessing nanotopography and integrin-matrix interactions to influence stem cell fate. Nat Mater. 13(6):558–569.
  • Dalby MJ, Gadegaard N, Riehle MO, Wilkinson CDW, Curtis ASG. 2004. Investigating filopodia sensing using arrays of defined nano-pits down to 35 nm diameter in size. Int J Biochem Cell Biol. 36(10):2005–2015.
  • Dalby MJ, Gadegaard N, Tare R, Andar A, Riehle MO, Herzyk P, Wilkinson CDW, Oreffo ROC. 2007. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater. 6(12):997–1003.
  • Dalby MJ, Giannaras D, Riehle MO, Gadegaard N, Affrossman S, Curtis ASG. 2004. Rapid fibroblast adhesion to 27 nm high polymer demixed nano-topography. Biomaterials. 25(1):77–83.
  • Dalby MJ, Riehle MO, Johnstone H, Affrossman S, Curtis ASG. 2004. Investigating the limits of filopodial sensing: a brief report using SEM to image the interaction between 10 nm high nano-topography and fibroblast filopodia. Cell Biol Int. 28(3):229–236.
  • Dash S, Murthy PN, Nath L, Chowdhury P. 2010. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 67(3):217–223.
  • Donnelly H, Dalby MJ, Salmeron-Sanchez M, Sweeten PE. 2018. Current approaches for modulation of the nanoscale interface in the regulation of cell behavior. Nanomedicine. 14(7):2455–2464.
  • Forman D, Bauld L, Bonanni B, Brenner H, Brown K, Dillner J, Kampman E, Manczuk M, Riboli E, Steindorf K, et al. 2018. Time for a European initiative for research to prevent cancer: a manifesto for Cancer Prevention Europe (CPE). J Cancer Policy. 17:15–23.
  • Gadducci A, Conte PF. 2008. Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature. Int J Gynecol Cancer. 18(5):943–953.
  • Gates BD, Xu QB, Stewart M, Ryan D, Willson CG, Whitesides GM. 2005. New approaches to nanofabrication: molding, printing, and other techniques. Chem Rev. 105(4):1171–1196.
  • Gottlieb E, Armour SM, Harris MH, Thompson CB. 2003. Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ. 10(6):709–717.
  • Gouda R, Baishya H, Qing Z. 2017. Application of mathematical models in drug release kinetics of carbidopa and levodopa ER tablets. J Dev Drugs. 6:02.
  • Gu L, Mooney DJ. 2016. Biomaterials and emerging anticancer therapeutics: engineering the microenvironment. Nat Rev Cancer. 16(1):56–66.
  • Gunatillake PA, Adhikari R. 2003. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater. 5(1):1–16.
  • Hong S, Ergezen E, Lec R, Barbee KA. 2006. Real-time analysis of cell-surface adhesive interactions using thickness shear mode resonator. Biomaterials. 27(34):5813–5820.
  • Islam M, Sajid A, Mahmood MAI, Bellah MM, Allen PB, Kim YT, Iqbal SM. 2015. Nanotextured polymer substrates show enhanced cancer cell isolation and cell culture. Nanotechnology. 26(22):225101.
  • Jaaback K, Johnson N, Lawrie TA. 2016. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database Syst Rev. (11):CD005340.
  • Jain RK. 2013. Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. J Clin Oncol. 31(17):2205–2218.
  • Janson IA, Putnam AJ. 2015. Extracellular matrix elasticity and topography: material-based cues that affect cell function via conserved mechanisms. J Biomed Mater Res A. 103(3):1246–1258.
  • Jenkins V, Catt S, Banerjee S, Gourley C, Montes A, Solis-Trapala I, Monson K, Fallowfield L. 2013. Patients’ and oncologists’ views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study. Br J Cancer. 108(11):2264–2271.
  • Khalili AA, Ahmad MR. 2015. A review of cell adhesion studies for biomedical and biological applications. Int J Mol Sci. 16(8):18149–18184.
  • Kim DH, Provenzano PP, Smith CL, Levchenko A. 2012. Matrix nanotopography as a regulator of cell function. J Cell Biol. 197(3):351–360.
  • Koegler P, Clayton A, Thissen H, Santos GNC, Kingshott P. 2012. The influence of nanostructured materials on biointerfacial interactions. Adv Drug Deliv Rev. 64(15):1820–1839.
  • Langley RR, Fidler IJ. 2011. The seed and soil hypothesis revisited-the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer. 128(11):2527–2535.
  • Langyel E. 2010. Ovarian cancer development and metastasis. Am J Pathol. 177(3):1053–1064.
  • Lee LCY, Gadegaard N, de Andres MC, Turner LA, Burgess KV, Yarwood SJ, Wells J, Salmeron-Sanchez M, Meek D, Oreffo ROC, et al. 2017. Nanotopography controls cell cycle changes involved with skeletal stem cell self-renewal and multipotency. Biomaterials. 116:10–20.
  • Lim JY, Hansen JC, Siedlecki CA, Runt J, Donahue HJ. 2005. Human foetal osteoblastic cell response to polymer-demixed nanotopographic interfaces. J R Soc Interface. 2(2):97–108.
  • Loesberg WA, Te Riet J, van Delft F, Schon P, Figdor CG, Speller S, van Loon J, Walboomers XF, Jansen JA. 2007. The threshold at which substrate nanogroove dimensions may influence fibroblast alignment and adhesion. Biomaterials. 28(27):3944–3951.
  • Mathew G, Watson DI, Rofe AM, Baigrie CF, Ellis T, Jamieson GG. 1996. Wound metastases following laparoscopic and open surgery for abdominal cancer in a rat model. Br J Surg. 83(8):1087–1090.
  • McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. 2004. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell. 6(4):483–495.
  • Mei L, Xu K, Zhai Z, He S, Zhu T, Zhong W. 2019. Doxorubicin-reinforced supramolecular hydrogels of RGD-derived peptide conjugates for pH-responsive drug delivery. Org Biomol Chem. 17(15):3853–3860.
  • Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. 2016. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 66(4):271–289.
  • Nakasone ES, Askautrud HA, Kees T, Park JH, Plaks V, Ewald AJ, Fein M, Rasch MG, Tan YX, Qiu J, et al. 2012. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell. 21(4):488–503.
  • Nikkhah M, Edalat F, Manoucheri S, Khademhosseini A. 2012. Engineering microscale topographies to control the cell-substrate interface. Biomaterials. 33(21):5230–5246.
  • Ogaki R, Lyckegaard F, Kingshott P. 2010. High-resolution surface chemical analysis of a trifunctional pattern made by sequential colloidal shadowing. Chemphyschem. 11(17):3609–3616.
  • Quail DF, Joyce JA. 2013. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 19(11):1423–1437.
  • Ramirez-San Juan GR, Oakes PW, Gardel ML. 2017. Contact guidance requires spatial control of leading-edge protrusion. Mol Biol Cell. 28(8):1043–1053.
  • Rodrigues MR, Lanzarini CM, Ricci-Junior E. 2011. Preparation, in vitro characterization and in vivo release of naproxen loaded in poly-caprolactone nanoparticles. Pharm Dev Technol. 16(1):12–21.
  • Rubin SC, Hoskins WJ, Saigo PE, Chapman D, Hakes TB, Markman M, Reichman B, Almadrones L, Lewis JL. 1991. Prognostic factors for recurrence following negative 2nd-look laparotomy in ovarian-cancer patients treated with platinum-based chemotherapy. Gynecol Oncol. 42(2):137–141.
  • Rybczynski J, Ebels U, Giersig M. 2003. Large-scale, 2D arrays of magnetic nanoparticles. Colloid Surf A Physicochem Eng Aspects. 219(1–3):1–6.
  • Schlie S, Gruene M, Dittmar H, Chichkov BN. 2012. Dynamics of cell attachment: adhesion time and force. Tissue Eng Part C Methods. 18(9):688–696.
  • Shard AG, Wang J, Spencer SJ. 2009. XPS topofactors: determining overlayer thickness on particles and fibres. Surf Interface Anal. 41(7):541–548.
  • Shard AG. 2012. A straightforward method for interpreting XPS data from core-shell nanoparticles. J Phys Chem C. 116(31):16806–16813.
  • Siegel R, Naishadham D, Jemal A. 2013. Cancer statistics, 2013. CA Cancer J Clin. 63(1):11–30.
  • Siegel RL, Miller KD, Jemal A. 2017. Cancer Statistics, 2017. CA Cancer J Clin. 67(1):7–30.
  • Sivandzade F, Bhalerao A, Cucullo L. 2019. Analysis of the mitochondrial membrane potential using the cationic JC-1 dye as a sensitive fluorescent probe. Bio-protocol. 9(1):e3128. eng.
  • Skoog SA, Kumar G, Narayan RJ, Goering PL. 2018. Biological responses to immobilized microscale and nanoscale surface topographies. Pharmacol Ther. 182:33–55.
  • Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Brawley OW, Wender RC. 2018. Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 68(4):297–316.
  • Sousa MP, Caridade SG, Mano JF. 2017. Control of cell alignment and morphology by redesigning ECM-mimetic nanotopography on multilayer membranes. Adv Healthcare Mater. 6(15):1601462.
  • Stevens MM, George JH. 2005. Exploring and engineering the cell surface interface. Science. 310(5751):1135–1138.
  • Sun H, Mei L, Song C, Cui X, Wang P. 2006. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials. 27(9):1735–1740.
  • Wang Y, Li P, Kong L. 2013. Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery. AAPS PharmSciTech. 14(2):585–592.
  • Wong BS, Teoh S-H, Kang L. 2012. Polycaprolactone scaffold as targeted drug delivery system and cell attachment scaffold for postsurgical care of limb salvage. Drug Deliv Transl Res. 2(4):272–283.
  • Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH. 2001. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 61(12):4766–4772.
  • Woodruff MA, Hutmacher DW. 2010. The return of a forgotten polymer-polycaprolactone in the 21st century. Prog Polym Sci. 35(10):1217–1256. English.
  • Yao X, Peng R, Ding J. 2013. Cell-material interactions revealed via material techniques of surface patterning. Adv Mater Weinheim. 25(37):5257–5286.
  • Yaşayan G, Orun O, Mega Tiber P, Rožman V, Koçyiğit Sevinç S. 2019. The interactions of human ovarian cancer cells and nanotextured surfaces: cell attachment, viability and apoptosis studies. RSC Adv. 9(45):25957–25966.
  • Yaşayan G, Xue X, Collier P, Clarke P, Alexander MR, Marlow M. 2016. The influence of nanotexturing of poly(lactic-co-glycolic acid) films upon human ovarian cancer cell attachment. Nanotechnology. 27(25):255102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.